Related Experiment Video
Updated: Jul 2, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis
Ying Liu1,2, Sixin Li1,2, Lu Chen3,4
1Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Background:
Tumor vaccines have become crucial in cancer immunotherapy, but, only a limited number of phase III clinical trials have demonstrated clinical efficacy. The crux of this issue is the inability of tumor vaccines to effectively harmonize the tumor microenvironment with its intricate interplay. One factor that can hinder the effectiveness of vaccines is the natural immunosuppressive element present in the tumor microenvironment. This element can lead to low rates of T-cell response specific to antigens and the development of acquired resistance. Conversely, anticancer vaccines alter the tumor microenvironment in conflicting manners, inducing both immune activation and immunological evasion. Hence, comprehending the correlation between tumor vaccines and the tumor microenvironment would establish a foundation for forthcoming tumor treatment.
Objective:
Our review explores the realm of research pertaining to tumor vaccinations and the tumor microenvironment. Our objective is to investigate the correlation between tumor vaccines and the tumor microenvironment within this domain. We then focus our review on the dominant international paradigms in this research field and visually illustrates the historical progression and emergent patterns observed in the past.
Methods:
From January 1, 1999 to February 7, 2023, 1420 articles on the interplay between tumor vaccines and the tumor microenvironment were published, according to The Clarivate Web of Science (WOS) database used in our review. A bibliometric review was designed for this collection and consisted of an evaluation. The evaluation encompassed various discernible attributes, including the year of publication, the journals in which the articles were published, the authors involved, the affiliated institutions, the geographical locations of the institutions, the references cited, and the keywords employed.
Results:
Between the years 1999 and 2022, publications saw a significant increase, from 3 to 265 annually. With 72 papers published, Frontiers in Immunology had the most manuscripts published. The Cancer Research publication garnered the highest number of citations, amounting to 2874 citations. The United States exerts significant dominance in the subject, with the National Cancer Institute being recognized as a prominent institution in terms of both productivity and influence. Furthermore, Elizabeth M. Jaffee was recognized as the field's most prolific and influential author with 24 publications and 1,756 citations. The co-occurrence cluster analysis was conducted on the top 197 keywords, resulting in the identification of five distinct clusters. The most recent high-frequency keywords, namely immune therapy, dendritic cell, tumor microenvironment, cancer, and vaccine, signify the emerging frontiers in the interaction between tumor vaccines and the tumor microenvironment.
Conclusion:
Our review uncovers insights into contemporary trends, global patterns of collaboration, fundamental knowledge, research areas of high interest, and emerging frontiers in the field of TME-targeted vaccines.
Insights
This review analyzes tumor vaccines and the tumor microenvironment, revealing key trends and emerging frontiers in cancer immunotherapy research. Understanding this interplay is vital for developing effective cancer treatments.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Tumor vaccines are crucial in cancer immunotherapy, but clinical efficacy is limited due to the immunosuppressive tumor microenvironment (TME).
- The TME's complex interplay with vaccines can lead to low T-cell responses and acquired resistance.
- Understanding the vaccine-TME correlation is essential for advancing cancer treatment strategies.
Purpose of the Study:
- To review research on tumor vaccinations and the TME.
- To investigate the correlation between tumor vaccines and the TME.
- To identify dominant international research paradigms, historical progression, and emergent patterns.
Main Methods:
- Bibliometric review of 1420 articles from 1999-2023 from the Web of Science database.
- Evaluation of publication year, journals, authors, institutions, geography, citations, and keywords.
- Co-occurrence cluster analysis of top 197 keywords.
Main Results:
- Publication output increased significantly from 3 to 265 articles annually (1999-2022).
- Frontiers in Immunology published the most papers (72); Cancer Research had the most citations (2874).
- The United States dominated research, with the National Cancer Institute and Elizabeth M. Jaffee as highly influential.
- Five keyword clusters were identified, with "immune therapy," "dendritic cell," "tumor microenvironment," "cancer," and "vaccine" as emerging frontiers.
Conclusions:
- The review provides insights into current trends, global collaborations, and fundamental knowledge in TME-targeted vaccines.
- It highlights key research areas and emerging frontiers in the interaction between tumor vaccines and the TME.
- This understanding is crucial for developing next-generation cancer immunotherapies.
Related Concept Videos
The Tumor Microenvironment
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle

